Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020


  • Published On : Dec-2014 |
  • Pages : 92 Pages |
  • Format :

Disposable plastic blood bags refer to the biomedical devices that are used for collection, storage, transportation, and transfusion of blood and its various components, such as red blood cells, white blood cells, and platelets. These blood bags are commonly made from plastic materials and polyvinyl chloride (PVC), and their manufacturing process includes compounding, extrusion, molding, welding, solution, sterilization, and inspection for contamination. There are different types of disposable blood bags based on the need of blood infusion; single blood bag, double blood bag, triple blood bag, quadruple blood bag and transfer blood bag. A blood bag package consists of collection tube, needle, needle cover, and a clamp. The disposable plastic blood bags have replaced the usage of glass bottle for collection and storage of blood and blood components. This is due to various features offered with disposable plastic bags, such as it enables the separation of blood components in a more sterile manner and eliminate the requirement of cleaning processes. It also reduces the chances of breakage during transportation. Globally, factors such as increasing cases of blood disorders have helped in the growth of disposable plastic blood bags market. 

North America dominates the global disposable plastic blood bags market. The U.S. represents the largest market for disposable plastic blood bags followed by Canada in North American region. This is due to increasing prevalence of blood disorders in the region. Asia is expected to experience high growth rate in the next five years in global disposable plastic blood bags market. This is due to large population base in the region and increasing demand for blood transfusion processes. China and India are expected to be the fastest growing disposable plastic blood bags markets in Asia.

Some of the major factors that are driving the global market for disposable plastic blood bags market are growing prevalence of chronic diseases, advanced features of disposable plastic blood bags, rising aging population and increasing initiatives undertaken by various government associations spreading awareness about importance of blood donations. However factors such as lack of primary healthcare infrastructure in developing countries, risks associated with blood transfusion and lack of awareness and poor blood collection and storage infrastructure in various parts of the world are restraining the global disposable plastic blood bags market. Rising number of mergers and acquisitions and increased use of RFID technology for easy and accurate identification of blood bags are some of the latest trends that have been observed in the global disposable plastic blood bags market. 

This report provides in-depth analysis and estimation of the disposable plastic blood bags market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The disposable plastic blood bags market is categorized on the basis of type of bags, end users and geography. Based on type, the disposable plastic blood bags market comprises single blood bags, double blood bags, triple blood bags and quadruple blood bags. Based on end users, the market comprises hospital and healthcare institutes, blood banks and home healthcare. 

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). North America is further segmented into the U.S., Canada and rest of North America. Similarly, Europe is further segmented into Germany, France, U.K., Italy and rest of Europe. Asia is further segmented into China, India, Japan and rest of Asia.

Disposable plastic blood bags refer to the biomedical devices that are used for collection, storage, transportation, and transfusion of blood and its components. Globally, the disposable plastic blood bags market is witnessing significant growth due to increasing prevalence of blood related disorders and advancement in the technology. In addition, growing aging population and rising government initiatives in the field are driving the disposable plastic blood bags market. However, factors such as risk associated with the blood transfusion and lack of awareness are restraining the global market for disposable plastic blood bags. In addition, poor healthcare infrastructure negatively impacts the growth of the global disposable plastic blood bags market. The global disposable plastic blood bags market is estimated at USD 2,44,286.8 thousand in 2014. It is likely to grow with a CAGR of 9.1% and reach USD 4,13,084.8 thousand in 2020.

North America has the largest market for the global disposable plastic blood bags market. Single blood bags are the largest segment in the overall disposable plastic blood bags market. In end users market, hospitals are the largest segment. In terms of growth, Asia is the fastest growing region, single blood bags are the fastest growing type of bags and blood banks are the fastest growing type of end users.

North America market for disposable plastic blood bags is estimated at USD 83,670.7 thousand in 2014 and is expected to reach USD 1,42,983.2 thousand in 2020, growing at a CAGR of 9.3%. Some of the latest trends that have been observed in the global disposable plastic blood bags market are the growing number of mergers and acquisitions by companies and increasing use of RFID technology for easy identification of blood bags.

Terumo Corporation is a leading player in the global disposable plastic blood bags market, with a share of about 38.7% in 2013. Some of the other major players in disposable plastic blood bags market are Fresenius SE & Co. KGaA, Grifols, S.A., MacoPharma SA, Haemonetics Corporation and others.

Some of the major players in the disposable plastic blood bags market:

  • Terumo Corporation.
  • Fresenius SE & Co.
  • KGaA.
  • Grifols.
  • S.A.
  • MacoPharma SA.
  • Haemonetics Corporation.
  • Other.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Table of Content

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology

1.3 Assumptions

Chapter 2 Market Synopsis

Chapter 3 Porter’s Five Forces Analysis

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Intensity of Rivalry

Chapter 4 Industry Overview

4.1 Market Definition

4.2 Market Drivers

     4.2.1 Increasing prevalence of chronic diseases

     4.2.2 Rising aging population

     4.2.3 Increasing initiatives undertaken by various government associations spreading awareness about importance of blood donations

     4.2.4 Advanced features of disposable plastic blood bags

4.3 Impact Analysis of Market Drivers

4.4 Market Restraints

     4.4.1 Risks associated with blood transfusion and lack of awareness

     4.4.2 Poor blood collection and storage infrastructure in various parts of the world

     4.4.3 Lack of primary healthcare infrastructure in developing countries

4.5 Impact Analysis of Market Restraints

4.6 Market Trends

     4.6.1 Increasing number of mergers and acquisitions

     4.6.2 Increasing use of RFID technology in blood bags

4.7 Market Opportunities

     4.7.1 Usage of non-PVC materials in blood bag

Chapter 5 Global Market Size and Forecast

5.1 On the Basis of Geography

5.2 On the Basis of Type

5.3 On the Basis of End Users

Chapter 6 Market Size and Forecast by Type

6.1 Single Blood Bags

6.2 Double Blood Bags

6.3 Triple Blood Bags

6.4 Quadruple Blood Bags

Chapter 7 Market Size and Forecast by End Users

7.1 Hospital and Healthcare Institutes

7.2 Blood Banks

7.3 Home Healthcare

Chapter 8 Market Size and Forecast by Geography

8.1 North America

8.2 Europe

8.3 Asia

Chapter 9 Competitive Scenario

9.1 Competitive Benchmarking

9.2 Company Share Analysis

Chapter 10 Company Profiles

10.1 Haemonetics Corporation

       10.1.1 Company overview

       10.1.2 Products and services

       10.1.3 Financial performance

       10.1.4 Key developments

10.2 Grifols, S.A.

       10.2.1 Company overview

       10.2.2 Products and services

       10.2.3 Financial performance

       10.2.4 Key developments

10.3 JMS Co., Ltd.

       10.3.1 Company overview

       10.3.2 Products and services

       10.3.3 Financial performance

       10.3.4 Key developments

10.4 Kawasumi Laboratories, Inc.

       10.4.1 Company overview

       10.4.2 Products and services

       10.4.3 Financial performance

       10.4.4 Key developments

10.5 AdvaCare Pharma

       10.5.1 Company overview

       10.5.2 Products and services

       10.5.3 Financial performance

       10.5.4 Key developments

10.6 Fresenius SE & Co. KGaA

       10.6.1 Company overview

       10.6.2 Products and services

       10.6.3 Financial performance

       10.6.4 Key developments

10.7 Terumo Corporation

       10.7.1 Company overview

       10.7.2 Products and services

       10.7.3 Financial performance

       10.7.4 Key developments

10.8 MacoPharma, S.A.

       10.8.1 Company overview

       10.8.2 Products and services

       10.8.3 Financial performance

       10.8.4 Key developments

10.9 GenesisBPS

       10.9.1 Company overview

       10.9.2 Products and services

       10.9.3 Financial performance

       10.9.4 Key development

10.10 SURU International Pvt. Ltd.

       10.10.1 Company overview

       10.10.2 Products and services

       10.10.3 Financial performance

       10.10.4 Key developments

10.11 Shanghai Transfusion Technology Co., Ltd.

       10.11.1 Company overview

       10.11.2 Products and services

       10.11.3 Financial performance

       10.11.4 Key developments

10.12 Sichuan Nigale Biomedical Co., Ltd.

       10.12.1 Company overview

       10.12.2 Products and services

       10.12.3 Financial performance

       10.12.4 Key developments

10.13 Neomedic Limited

       10.13.1 Company overview

       10.13.2 Products and services

       10.13.3 Financial performance

       10.13.4 Key developments

10.14 Shandong Weigao Group Medical Polymer Co., Ltd.

       10.14.1 Company overview

       10.14.2 Products and services

       10.14.3 Financial performance

       10.14.4 Key developments


List of Table

TABLE 1 Market snapshot: Global market of disposable plastic blood bags (2014 and 2020) 11

TABLE 2 Drivers for disposable plastic blood bags market: Impact analysis 21

TABLE 3 Restraints for disposable plastic blood bags market: Impact analysis 24

TABLE 4 Some of the major mergers and acquisitions in disposable plastic blood bags market 25

TABLE 5 Global disposable plastic blood bags market size, by region, 2010 – 2013 (USD thousand) 29

TABLE 6 Global disposable plastic blood bags market size, by region, 2014 – 2020 (USD thousand) 29

TABLE 7 Global disposable plastic blood bags market size, by type, 2010 – 2013 (USD thousand) 31

TABLE 8 Global disposable plastic blood bags market size, by type, 2014 – 2020 (USD thousand) 31

TABLE 9 Global disposable plastic blood bags market size, by end users, 2010 – 2013 (USD thousand) 33

TABLE 10 Global disposable plastic blood bags market size, by end users, 2014 – 2020 (USD thousand) 33

TABLE 11 Global single blood bags market size, by region, 2010 – 2013 (USD thousand) 35

TABLE 12 Global single blood bags market size, by region, 2014 – 2020 (USD thousand) 35

TABLE 13 Global double blood bags market size, by region, 2010 – 2013 (USD thousand) 37

TABLE 14 Global double blood bags market size, by region, 2014 – 2020 (USD thousand) 37

TABLE 15 Global triple blood bags market size, by region, 2010 – 2013 (USD thousand) 38

TABLE 16 Global triple blood bags market size, by region, 2014 – 2020 (USD thousand) 39

TABLE 17 Global quadruple blood bags market size, by region, 2010 – 2013 (USD thousand) 41

TABLE 18 Global quadruple blood bags market size, by region, 2014 – 2020 (USD thousand) 41

TABLE 19 Global hospital and healthcare institutes market size, by region, 2010 – 2013 (USD thousand) 43

TABLE 20 Global hospital and healthcare institutes market size, by region, 2014 – 2020 (USD thousand) 43

TABLE 21 Global blood banks market size, by region, 2010 – 2013 (USD thousand) 44

TABLE 22 Global blood banks market size, by region, 2014 – 2020 (USD thousand) 45

TABLE 23 Global home healthcare market size, by region, 2010 – 2013 (USD thousand) 46

TABLE 24 Global home healthcare market size, by region, 2014 – 2020 (USD thousand) 47

TABLE 25 North American disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 49

TABLE 26 North American disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 50

TABLE 27 European disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 52

TABLE 28 European disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 53

TABLE 29 Asian disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 55

TABLE 30 Asian disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 56

TABLE 31 Products and services categories of Haemonetics Corporation 60

TABLE 32 Products and services categories of Grifols, S.A. 62

TABLE 33 Products and services categories of JMS 66

TABLE 34 Products and services categories of Kawasumi Laboratories, Inc. 68

TABLE 35 Products and service categories of AdvaCare Pharma 70

TABLE 36 Products and services categories of Fresenius SE & Co. KGaA 72

TABLE 37 Products and services categories of Terumo Corporation 75

TABLE 38 Products and service categories of MacoPharma, S.A. 77

TABLE 39 Products and service categories of GenesisBPS 79

TABLE 40 Products and service categories of SURU International Pvt. Ltd. 81

TABLE 41 Plasma and blood products and services categories of Sichuan Nigale Biomedical Co., Ltd. 85

TABLE 42 Plasma and blood products and services categories of Neomedic Limited 88

TABLE 43 Products and services categories of Weigao Group 89


List of Figure


FIG. 1 Disposable plastic blood bags market: Porter’s five force analysis 13

FIG. 2 Disposable plastic blood bags market, by type 16

FIG. 3 Aging population in major countries, 2000 – 2050 (% share in total population) 19

FIG. 4 Global disposable plastic blood bags market share, by region, by value, 2013 28

FIG. 5 Global disposable plastic blood bags market share, by type, by value, 2013 30

FIG. 6 Global disposable plastic blood bags market share, by end users, by value, 2013  32

FIG. 7 Global single blood bags market share, by region, by value, 2013 34

FIG. 8 Global double blood bags market share, by region, by value, 2013 36

FIG. 9 Global triple blood bags market share, by region, by value, 2013 38

FIG. 10 Global quadruple blood bags market share, by region, by value, 2013 40

FIG. 11 Global hospital and healthcare institutes market share, by region, by value, 2013  42

FIG. 12 Global blood banks market share, by region, by value, 2013 44

FIG. 13 Global home healthcare market share, by region, by value, 2013 46

FIG. 14 North American disposable plastic blood bags market share, by country, by value, 2013 49

FIG. 15 European disposable plastic blood bags market share, by country, by value, 2013  52

FIG. 16 Asian disposable plastic blood bags market share, by country, by value, 2013 55

FIG. 17 Competitive landscape of disposable plastic blood bag providers, 2013 57

FIG. 18 Global disposable plastic blood bags market, by company, 2013 (% share) 58

FIG. 19 Haemonetics Corporation’s net revenue and net income, 2012 – 2014 (USD million) 60

FIG. 20 Grifols’ net sales and profit after tax, 2011 – 2013 (USD million) 64

FIG. 21 JMS’ net sales and net income, 2012 – 2014 (USD million) 67

FIG. 22 Kawasumi Laboratories, Inc.’s net sales and net income, 2012 – 2014 (USD million) 69

FIG. 23 Fresenius SE & Co. KGaA’s sales and net income, 2011 – 2013 (USD billion) 73

FIG. 24 Terumo Corporation’s net sales and net income, 2012 – 2014 (USD million) 76

FIG. 25 Weigao Group’s revenue and profit, 2011 – 2013 (USD million) 90

Back To Top